US invests over $240 million into seven new COVID-19 diagnostic tests
The National Institutes of Health in the US has awarded contracts to seven biomedical companies to develop and manufacture COVID-19 diagnostics.
List view / Grid view
The National Institutes of Health in the US has awarded contracts to seven biomedical companies to develop and manufacture COVID-19 diagnostics.
3 May 2013 | By kdm communications limited
The new system will help the DKMS accelerate...
25 April 2013 | By kdm communications limited
The official opening of the Single-Cell Omics Centre (SCOC)...